Literature DB >> 17304458

Hemorrhagic hereditary telangiectasia (Rendu-Osler disease) and infectious diseases: an underestimated association.

Sophie Dupuis-Girod1, Sophie Giraud, Evelyne Decullier, Gaetan Lesca, Vincent Cottin, Frédéric Faure, Olivier Merrot, Jean-Christophe Saurin, Jean-François Cordier, Henri Plauchu.   

Abstract

Among 353 patients with hereditary hemorrhagic telangiectasia retrospectively analyzed during the period 1985-2005, we identified 67 cases of severe infection that affected 48 patients (13.6%). Extracerebral infections accounted for 67% of all infections, and most involved Staphylococcus aureus and were associated with prolonged epistaxis. Cerebral infections accounted for 33% of all infections, were mainly due to multiple and anaerobic bacteria, and were associated with the presence of pulmonary arteriovenous malformations and a short duration of epistaxis.

Entities:  

Mesh:

Year:  2007        PMID: 17304458     DOI: 10.1086/511645

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  26 in total

1.  Pulmonary arteriovenous fistula in hereditary hemorrhagic telangiectasis.

Authors:  Olaf Franzen; Christian Lund; Stephan Baldus
Journal:  Clin Res Cardiol       Date:  2009-11       Impact factor: 5.460

2.  Prevention of serious infections in hereditary hemorrhagic telangiectasia: roles for prophylactic antibiotics, the pulmonary capillaries-but not vaccination.

Authors:  Claire Shovlin; Kathleen Bamford; Carlo Sabbà; Hans-Jurgen Mager; Anette Kjeldsen; Freya Droege; Elisabetta Buscarini; Sophie Dupuis-Girod
Journal:  Haematologica       Date:  2019-02       Impact factor: 9.941

3.  Infection prevention in patients with hereditary hemorrhagic telangiectasia.

Authors:  Juan Rodríguez-García; Roberto Zarrabeitia-Puente; Rafael Fernández-Santos; José Antonio García-Erce
Journal:  Haematologica       Date:  2018-10       Impact factor: 9.941

4.  Infections and vaccination in hereditary hemorrhagic telangiectasia: microbiological evidence-based considerations.

Authors:  Hanny Al-Samkari; Athena Kritharis; David J Kuter
Journal:  Haematologica       Date:  2018-10       Impact factor: 9.941

Review 5.  Hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations: clinical aspects.

Authors:  Nathaniel M Meier; Michael L Foster; John T Battaile
Journal:  Cardiovasc Diagn Ther       Date:  2018-06

6.  Complications and mortality in hereditary hemorrhagic telangiectasia: A population-based study.

Authors:  James W Donaldson; Tricia M McKeever; Ian P Hall; Richard B Hubbard; Andrew W Fogarty
Journal:  Neurology       Date:  2015-04-10       Impact factor: 9.910

7.  Recurrent erysipelas led to diagnosis of hereditary hemorrhagic telangiectasia.

Authors:  Mari Yamaoka; Yohei Kanzawa; Shun Tatehara; Koji Sasaki; Shimpei Mizuki; Jun Ohnishi; Takahiro Nakajima; Naoto Ishimaru; Saori Kinami
Journal:  Infez Med       Date:  2022-03-01

8.  Pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia: Correlations between computed tomography findings and cerebral complications.

Authors:  Johan Etievant; Salim Si-Mohamed; Nicolas Vinurel; Sophie Dupuis-Girod; Evelyne Decullier; Delphine Gamondes; Chahera Khouatra; Vincent Cottin; Didier Revel
Journal:  Eur Radiol       Date:  2017-10-10       Impact factor: 5.315

9.  Prevalence of hereditary hemorrhagic telangiectasia in patients operated for cerebral abscess: a retrospective cohort analysis.

Authors:  L Larsen; C R Marker; A D Kjeldsen; F R Poulsen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-06-03       Impact factor: 3.267

10.  Thalamic abscess in a patient with hereditary hemorrhagic telangiectasia successfully treated with an empiric antibiotic regime: case report and review of the literature.

Authors:  Xavier A Santander; Anwar Saab; Juan Manuel Revuelta-Barbero; Elena Múñez
Journal:  BMC Infect Dis       Date:  2021-03-19       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.